Hemostasis Learning Essentials - Series 4 Assessment

Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Untitled Scene Master Template HOOD05162003052540 | Effective Date: 26-Nov-2019 Hemostasis Learning Essentials Series 4 – Anticoagulant Therapy Assessment This assessment covers the content in the Series 4 topic. Welcome ? Objectives-Series 4 Webinars It is recommended that the webinars in the Hemostasis Learning Essentials Series 4- Anticoagulant Therapy are completed prior to taking this assessment. Select each webinar title to review the learning objectives. Anticoagulants Other than DOACs Webinar The Use of DOACs in Older Individuals Webinar Objectives The Use of DOACs in Older Individuals Webinar At the end of this session you will be able to: Explain the indications for anticoagulation Define DOACs and NOACs and how they work Explain how DOACs are started in atrial fibrillation Explain how DOACs affect coagulation tests Identify precautions to take when precscribing DOACs Explain how to deal with bleeding and surgeries for patient under DOAC therapy Anticoagulants Other than DOACs Webinar At the end of this session you will be able to: Explain how heparin works as an anticoagulant therapy Describe the adverse effects of heparin and heparin resistance Explain how heparin-induced thrombocytopenia (HIT) is managed Explain the role of direct thrombin Inhibitors Describe how to monitor parenteral anticoagulants Explain how warfarin works as an anticoagulant therapy and describe potential issues after stopping warfarin Disclaimer Please note that the learning material is for training purposes only. For the proper use of the software or hardware, please always use the Operator Manual or Instructions for Use (hereinafter collectively “Operator Manual”) issued by Siemens Healthineers. This material is to be used as training material only and shall by no means substitute the Operator Manual. Any material used in this training will not be updated on a regular basis and does not necessarily reflect the latest version of the software and hardware available at the time of the training. The Operator Manual shall be used as your main reference, in particular for relevant safety information like warnings and cautions. Please note: Some functions shown in this material are optional and might not be part of your system. Certain products, product related claims or functionalities (hereinafter collectively “Functionality”) may not (yet) be commercially available in your country. Due to regulatory requirements, the future availability of said Functionalities in any specific country is not guaranteed. Please contact your local Siemens Healthineers sales representative for the most current information. The reproduction, transmission or distribution of this training or its contents is not permitted without express written authority. Offenders will be liable for damages. All names and data of patients, parameters and configuration dependent designations are fictional and examples only. All rights, including rights created by patent grant or registration of a utility model or design, are reserved. Unrestricted | Published by Siemens Healthineers AG | © Siemens Healthineers AG, 2024 Siemens Healthineers HQ | Siemens Healthineers AG Siemensstr. 3 91301 Forchheim Germany Phone: +49 9191 18-0 siemens-healthineers.com ? Disclaimer Assessment Start ? This assessment will test your retention of the presented content. A passing score of 80% or higher is required to complete the course and earn your certificate . Assessment questions must be answered completely to receive full credit. Partial credit will not be given for assessment questions that require multiple answers. You may repeat the assessment as many times as needed. Assessment Select the best answer. ? Reduction of ischemic stroke Increase of Hemorrhagic stroke Question 1 of 11 Which of the following is associated with the increased usage of anticoagulation therapy (Warfarin)? Increase of ischemic stroke Reduction of Hemorrhagic stroke Multiple Choice ? Select three (3) answers. Question 2 of 11 Increased D-Dimer levels Which of the following are adverse effects of heparin? Bleeding Injection site reactions Weight loss Osteoporosis if prolonged use Multiple Answer One or more answers are incorrect. Select the best answer. ? PF4 (Platelet Factor 4) Monocyte Question 3 of 11 When combined with heparin, which of the following can create HIT (Heparin Induced Thrombocytopenia) antibodies in some patients? Heparin sulfate B-lymphocyte Multiple Choice ? Select two (2) answers. Question 4 of 11 The 4T Score helps to determine which of the following? The probability of a patient developing HIT If laboratory analysis is needed The platelet count fall The probability of falling platelet count Multiple Answer One or more answers are incorrect. ? Select three (3) answers. Question 5 of 11 In which settings is anti-Xa monitoring preferred? With critically ill children and adults In the presence of lupus anticoagulant When there is prothrombin deficiency When heparin resistance is suspected Multiple Answer One or more answers are incorrect. ? Select three (3) answers. Question 6 of 11 What can cause a high INR after stopping Warfarin? Undiagnosed liver disease Antibiotics and other drugs which can prolong warfarin bioavailability Chronic inflammation Vitamin K deficiency Multiple Answer One or more answers are incorrect. ? Select three (3) answers. Question 7 of 11 When considering the efficacy and safety of DOACs vs warfarin which of the following is true? DOACs are less likely to cause intracranial hemorrhage Warfarin is less likely to cause gastrointestinal bleeding Warfarin is better at preventing haemorrhagic strokes DOACs and warfarin are equally good at preventing ischaemic stroke Multiple Answer One or more answers are incorrect. ? Select three (3) answers. Question 8 of 11 Which of the following DOACs are Anti-Xa agents? Rivaroxaban Apixaban Dabigatran Edoxaban Multiple Answer One or more answers are incorrect. Select the best answer. ? TT – Thrombin Time Question 9 of 11 Which clotting test does Dabigatran affect the most? APTT – Activated Partial Thrombin Time PT – Prothrombin Time Multiple Choice ? Select three (3) answers. Question 10 of 11 Which of the following should be considered when prescribing DOACs? Kidney function Drug interactions Chronic inflammation Bleeding and surgeries Multiple Answer One or more answers are incorrect. Select the best answer. ? Atrial fibrillation Vitamin K deficiency Question 11 of 11 What is the most common reason for prescribing DOACs? High risk of thrombosis High risk of intracranial hemorrhage Multiple Choice Assessment Results YOUR SCORE: PASSING SCORE: Review Retry Retry Continue Continue Continue %Results.ScorePercent%% %Results.PassPercent%% ? Assessment Results You did not pass the course. Take time to review the assessment then select Retry to continue. Congratulations. You passed the course.. Exit To access your Certificate of Completion, select the Certificates tab from the learning activity overview page. You can also access the certificate from your PEPconnect transcript. ? You have completed the Hemostasis Learning Essentials Series 4-Anticoagulant Therapy Assessment. Completion details, certificates tab Navigation Help Select the icon above to open the table of contents. Click Next to continue. Next Welcome Slide The timeline displays the slide progression. Slide the orange bar backwards to rewind the timeline. Click Next to continue. Next Tmeline Select the CC icon to display closed captioning (subtitles). Click Next to continue. Next Caption Icon Select the buttons to learn more about a topic. Be sure to review all topics before navigating to the next slide. Click Next to continue. Next Tab Arrow Slide Select the X to close the pop-up. Click Next to continue. Next Layer Slide Some images may have a magnifier icon. Select the image to see an enlarged view. Select it again to return to the normal view. Click Next to continue. Next Zoom Slide Some images have a magnifier icon in the bottom-left corner. Select these image to see an enlarged view of the image. Select the image again to return to the normal view. Videos should default to the optimal resolution. However, to change the video resolution select the gear icon. Click Next to continue. Next Video Slide Some images have a magnifier icon in the bottom-left corner. Select these image to see an enlarged view of the image. Select the image again to return to the normal view. Select Submit to record your response. Click the X in the upper right corner to exit the navigation help. Assessment Slide Question Bank 1 QR700007509| Effective Date: 23 Apr 2024 1.1 Welcome 1.2 Objectives 1.3 Disclaimer 1.4 Assessment